Dr. Jane
November 9, 2022
Further studies by Strober and others, including study co-author and professor of medicine Judith Shizuru, MD, PhD, showed it’s possible to hobble, rather than eliminate, the recipient’s immune system before introducing the donor’s stem cells. The result is a hybrid immune system, made up of both donor and recipient stem cells, and a reduced likelihood of graft-versus-host disease. The hybrid, …
Dr. Jane
November 8, 2022
The Duke Human Vaccine Institute is tackling an epidemic that has claimed 40.1 million lives and continues to impact tens of millions more across the world. Guido Ferrari, professor of surgery and research professor of molecular genetics and microbiology, and Wilton Bryan Williams, associate professor of surgery and medicine and assistant professor of immunology, are currently leading a research project …
Dr. Jane
November 5, 2022
MANHASSET, NY–(BUSINESS WIRE)–Electrically stimulating the vagus nerve has shown potential to treat inflammatory diseases, including rheumatoid arthritis, lupus and diabetes. Now, a team of bioelectronic medicine scientists at The Feinstein Institutes for Medical Research is one step closer to developing more precise, selective neuromodulation techniques. A new paper published in brain stimulation showed that delivering high-frequency electrical stimulation activates specific …
Dr. Jane
September 10, 2022
Ashok Kumar, Ph.D., at left, and Susmita Das, Ph.D. Researchers from the Department of Ophthalmology, Visual and Anatomical Sciences at the Wayne State University School of Medicine have identified three non-antibiotic drugs can protect the eye from severe inflammation during bacterial infection. The drugs can also be used as adjunct therapy with standard antibiotics to minimize infection outcomes. The study …
The severe shortage of organs available for human transplant has forced researchers to get creative in generating new ones. Some have pinned their hopes on pigs; others aim to grow organs in a dish — but these efforts have been largely fruitless or plagued by complications. An approach that’s been simultaneously the most promising and the least successful is developing …
By Duxin Sun, University of Michigan When you hear the word “nanomedicine,” it might call to mind scenarios like those in the 1966 movie “Fantastic Voyage.” The film portrays a medical team shrunken down to ride a microscopic robotic ship through a man’s body to clear a blood clot in his brain. Nanomedicine has not reached that level of sophistication …
HYDERABAD: In a significant development, city researchers have successfully completed trials for dengue drug on animals and have now approached the Clinical Trials Registry-India (CTRI) for testing it on humans. Once approved by the CTRI, clinical trials on the novel drug for dengue will be conducted at AIIMS, Delhi. The researchers have also applied for registration of an international patent …
Dr. Jane
December 24, 2021
Scientists have identified a number of molecular candidates for the components of canine allergens that trigger immune responses in humans – the first step in developing a vaccine against most causes of canine allergies. There has been much research describing the nature and progression of dog allergies, but there have been very few applied studies that use this information to …
Dr. Jane
October 18, 2021
Paola Tiedemann, an academic professor of forensics in the Department of Environmental Toxicology at Texas Tech University, and Nathaniel Hall, an assistant professor of animal science in the College of Agricultural Sciences & Natural Resources, have received a $ 270,717 collaboration agreement from the U.S. Army Research Bureau to order To study how environmental factors affect the performance of explosive …
